Meeting
2023 ASCO Annual Meeting
Hereditary breast and ovarian cancer syndrome: A misnomer?
Authors
Jessica M. Weiss
New York Medical College, Valhalla, NY
Jessica M. Weiss , Muhammad Danyal Ahsan , Emily M. Webster , Sarah R. Levi , Murtaza Qazi , Benedict Harvey , Evelyn Cantillo , Kevin Holcomb , Eloise Chapman-Davis , Ravi N. Sharaf , Melissa Kristen Frey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Hereditary Cancer Syndromes
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10594)
DOI
10.1200/JCO.2023.41.16_suppl.10594
Abstract #
10594
Poster Bd #
227
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan
Poster
2021 ASCO Annual Meeting
Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy.
First Author: Jessica A Lavery
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Prevalence of germline mutations and homologous recombination deficiency (HRD) in a real-world biliary tract cancer (BTC) cohort.
First Author: Robin Kate Kelley